fda glp‑1 restriction

fda glp‑1 restriction

45% Cut in Prescription Weight Loss Misinformation

4% of compounded GLP-1 batches have been linked to bacterial contamination, making a tiny “weight-loss” gummy that contains these agents both illegal and unsafe. The FDA’s new restrictions tighten control over semaglutide, tirzepatide and liraglutide, so patients must verify that any product is prescribed by a licensed prescriber. Medical